Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESRRG | P62508 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23795788 | 0.86 | HDAC1 (0.55) | HDAC1HDAC6CA1CA2CA9 | |
| SCHEMBL30881591 | 0.86 | HDAC1 (0.55) | HDAC1HDAC6CA1CA2CA9 | |
| SCHEMBL25970594 | 0.84 | JAK3 (0.42) | MAPTPOLBPDGFRBKDRESR1 | |
| SCHEMBL3790236 | 0.84 | MAPT (0.47) | HDAC1HDAC6CA1CA2CA9 | |
| SCHEMBL15279864 | 0.81 | ALDH1A1 (0.52) | MAPTNPC1RAB9APOLBALDH1A1 | |
| SCHEMBL14750323 | 0.79 | BTK (0.46) | — | |
| SCHEMBL30748254 | 0.78 | SMN1; SMN2 (0.55) | HDAC1HDAC6CA1CA2CA9 | |
| SCHEMBL8955980 | 0.78 | SMN1; SMN2 (0.55) | HDAC1HDAC6CA1CA2CA9 | |
| SCHEMBL13624846 | 0.77 | KMT2A (0.50) | MAPTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL9403860 | 0.77 | KDM4E (0.59) | HDAC1HDAC6CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10556914-B2 | Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use | ABBVIE INC. (US) | 2020-02-11 | — | — | US | disclosed |
| EP-3350187-A1 | SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE | AbbVie Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017046117-A1 | SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE | ABBVIE INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| US-20170073353-A1 | SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE | AbbVie Deutschland GmbH & Co. KG (DE) | 2017-03-16 | — | — | US | disclosed |
| EP-1601999-B1 | Holographic sensor and its use | SMART HOLOGRAMS LTD (GB) | 2013-04-24 | — | — | EP | disclosed |
| US-8241574-B2 | Ophthalmic device comprising a holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2012-08-14 | — | — | US | disclosed |
| US-8241574-B2 | Ophthalmic device comprising a holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2012-08-14 | — | — | US | disclosed |
| US-20120107944-A1 | Holographic Sensor | LOWE CHRISTOPHER ROBIN (GB) | 2012-05-03 | — | — | US | disclosed |
| US-20120107944-A1 | Holographic Sensor | LOWE CHRISTOPHER ROBIN (GB) | 2012-05-03 | — | — | US | disclosed |
| US-20110286064-A1 | OPHTHALMIC DEVICE COMPRISING A HOLOGRAPHIC SENSOR | BURLES BARRY (GB) | 2011-11-24 | — | — | US | disclosed |
| US-20110286064-A1 | OPHTHALMIC DEVICE COMPRISING A HOLOGRAPHIC SENSOR | BURLES BARRY (GB) | 2011-11-24 | — | — | US | disclosed |
| US-8048680-B2 | Holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-11-01 | — | — | US | disclosed |
| US-8048680-B2 | Holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-11-01 | — | — | US | disclosed |
| US-7998412-B2 | Ophthalmic device comprising a holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-08-16 | — | — | US | disclosed |
| US-7998412-B2 | Ophthalmic device comprising a holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-08-16 | — | — | US | disclosed |
| US-20090021697-A1 | Ophthalmic Device Comprising a Holographic Sensor | SMART HOLOGRAMS LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20090021697-A1 | Ophthalmic Device Comprising a Holographic Sensor | SMART HOLOGRAMS LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10556914-B2 | Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use | GABRB1, GABBR1, GABBR2 | HDAC1 2014/4885HDAC6 1347/4885CA1 2171/4885 |
| US-20170073353-A1 | SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE | GABRB1, GABBR1, GABBR2 | HDAC1 2014/4885HDAC6 1347/4885CA1 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.